Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Test Bank ISBN:9780826195463|Complete Guide A+

Test Bank:
xn



Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
xn xn xn xn xn xn xn xn x



Edition, 2024
n xn

, Table of Contents xn xn


Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
xn xn xn xn xn xn xn xn



Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
xn xn xn xn



Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
xn xn xn



Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
xn xn xn xn xn xn



Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
xn xn xn xn xn xn



Chapter 7: Drug Development and Approval........................................................................................... 45
xn xn xn xn xn



Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
xn xn xn xn xn xn xn xn xn


Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
xn xn xn xn xn



Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
xn xn xn xn xn



Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
xn xn xn xn xn xn xn xn xn


Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
xn xn xn xn xn xn xn xn xn xn xn


er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
xn xn xn xn xn



Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
xn xn xn xn xn



Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
xn xn xn xn xn



Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
xn xn xn xn xn



Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
xn xn xn xn xn



Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
xn xn xn xn xn xn xn xn xn


port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
xn xn xn xn xn



Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
xn xn xn xn xn xn xn xn xn



Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
xn xn xn xn xn xn xn



Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
xn xn xn xn xn xn xn



Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
xn xn xn xn xn



Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
xn xn xn xn xn



Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
xn xn xn xn xn xn xn xn



Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
xn xn xn xn xn xn xn



Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
xn xn xn xn xn xn xn



Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
xn xn xn xn xn xn



Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
xn xn xn



Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
xn xn xn



Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
xn xn xn xn xn xn xn xn xn xn


ocognitive Conditions ................................................................................................................................ 247
xn



Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
xn xn xn xn xn



Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
xn xn xn xn xn xn xn xn xn



Chapter 35: Over-the-Counter Medications ............................................................................................ 283
xn xn xn



Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
xn xn xn xn

,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
xn xn xn xn xn xn xn xn


MULTIPLE CHOICE xn




• What is the primary purpose of the nursing assessment?
xn xn xn xn xn xn xn xn




A. Identifying underlying pathologic conditions xn xn xn




B. Assisting the physician in identifying medical conditions
xn xn xn xn xn xn




C. Determining the patients mental status xn xn xn xn




D. Exploring patient responses to health problems xn xn xn xn xn




ANS: D xn




A nursing assessment is done to identify the patients response to health
xn xn xn xn xn xn xn xn xn xn xn xn


problems. During the nursing assessment phase, a comprehensive inform
xn xn xn xn xn xn xn xn


ation base is developed through a physical examination, nursing history,
xn xn xn xn xn xn xn xn xn x


medication history, and professional observation. Identifying underlying
n xn xn xn xn xn xn x


pathologic conditions and assisting the physician in identifying medical
n xn xn xn xn xn xn xn xn xn


conditions is not part of the nursing process. Determining the patients
xn xn xn xn xn xn xn xn xn xn xn


mental status is one part of the nursing assessment, but it is not the
xn xn xn xn xn xn xn xn xn xn xn xn xn x


primary purpose.
n xn




DIF: Cognitive Level: Comprehension
xn xn xn


REF: dm 36 OBJ: 1 | 3 TOP: Nursin
xn xn xn xn xn xn xn xn xn


g Process Step: Assessment
xn xn xn


MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
xn xn xn xn xn xn xn xn




• What is the basis of the NANDA I taxonomy?
xn xn xn xn xn xn xn x n




A. Functional health patterns xn xn




B. Human response patterns xn xn




C. Basic human needs xn xn




D. Pathophysiologic needs xn




ANS: B xn




The NANDA I taxonomy identifies human response patterns. Fu
x n x n x n x n x n x n x n xn


nctional components of health patterns are limited to activity, fluid vol
xn xn xn xn xn xn xn xn xn xn


ume, nutrition, self care, and sensory perception. Basic human needs c
xn xn xn xn xn xn xn xn xn xn


omprise less than merely health patterns. Pathophysiologic needs are
xn xn xn xn xn xn xn xn x n


not part of the scope of NANDA I.
xn xn xn xn xn xn xn

, DIF: Cognitive Level: Knowledge RE
xn xn xn xn


F: pp. 37-38 OBJ: 5 TOP:
xn xn xn xn xn


Nursing Process Step: Diagnosis
xn xn xn


MSC: NCLEX Client Needs Category: Physiological Integrity
xn xn xn xn xn xn




• Which task is included in the assessment step of the nursing process?
xn xn xn xn xn xn xn xn xn xn xn




A. Establishing patient goals/outcomes xn xn




B. Implementing the nursing care plan (NCP) xn xn xn xn xn




C. Measuring goal/outcome achievement xn xn




D. Collecting and communicating data xn xn xn




ANS: D xn




Data are collected and communicated in the assessment phase of the nur
xn xn xn xn xn xn xn xn xn xn xn


sing process. Establishing goals is the function of planning.
xn xn xn xn xn xn xn xn


Implementing the NCP is the function of implementation. Measuring out
xn xn xn xn xn xn xn xn xn


come achievement is the function of evaluation.
xn xn xn xn xn xn




DIF: Cognitive Level: Comprehensio
xn xn xn


n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
xn xn xn xn xn xn xn xn xn


ng Process Step: Assessment
xn xn xn


MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
xn xn xn xn xn xn xn xn




• Which statement regarding nursing diagnoses is accurate?
xn xn xn xn xn xn




a. Nursing diagnoses remain the same for as long as the disease is present.
xn xn xn xn xn xn xn xn xn xn xn xn




b. Nursing diagnoses are written to identify disease states.
xn xn xn xn xn xn xn




c. Nursing diagnoses describe patient problems that nurses treat.
xn xn xn xn xn xn xn




d. Nursing diagnoses identify causes related to illness.
xn xn xn xn xn xn




ANS: C xn




Diagnostic statements identify problems a nurse is independently able t
xn xn xn xn xn xn xn xn xn


o treat within the scope of professional practice. Nursing diagnoses var
xn xn xn xn xn xn xn xn xn xn


y with the changing condition of the patient. The response patterns are
xn xn xn xn xn xn xn xn xn xn xn xn


unique to the patient and are not disease specific. Nursing diagnoses de
xn xn xn xn xn xn xn xn xn xn xn


scribe the patients human response pattern.
xn xn xn xn xn




DIF: Cognitive Level: Comprehension
xn xn xn